Weight loss drugs like semaglutide may reduce knee pain from osteoarthritis offering a promising alternative to knee ...

A new study suggests that weekly self-injections of the weight loss drug semaglutide could reduce knee pain from moderate osteoarthritis by nearly 50%.

According to a 2023 study published in The Lancet Rheumatology, nearly 1 billion people worldwide will be affected by the most common form of arthritis: osteoarthritis. Currently, the condition ...